International Patent: HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATION AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS

GENEVA, Oct. 22 -- LA JOLLA INSTITUTE FOR IMMUNOLOGY filed a patent application (IB2025/058281) for “HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATION AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS”. With publication no. WO/2026/220188, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/775

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....